Acuity Pharmaceuticals Inc.

Private Company, Headquarters Location
3701 Market St., Philadelphia, PA 19104-5502, United States
(215)966-6191, (215)966-6001 fax, http://www.acuitypharma.com

Primary SIC: Commercial Physical & Bio Research, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: Bio research. Biomedical technologies for treating eye disease.

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

Acuity Pharmaceuticals Inc., News and Information

Researchers from University of Bari detail findings in macular degeneration.
Angiogenesis Weekly; 11/6/2009; 997 words; ...combined surgery, corrected distance visual acuity (CDVA), anterior chamber reaction...Refractive Surgery is: Elsevier Science Inc., 360 Park Avenue South, New York...Monoclonal Antibodies, Ophthalmology, Pharmaceuticals, Refractive Surgery, Therapy, Treatment...

Other News To Note.
BIOWORLD Today; 11/4/2009; 1686 words; ...not disclosed. o Ariad Pharmaceuticals Inc., of Cambridge, Mass...with Ariad. o Biomira Inc., of Edmonton, Alberta...shares. Rodman & Renshaw Inc., of New York, acted...early trends for visual acuity showed improvement of...

ISTA Receives FDA Go-Ahead To Submit NDA For Vitrase.
BIOWORLD Today; 11/4/2009; 848 words; ...meet its primary endpoint, ISTA Pharmaceuticals Inc. had good news to share Wednesday...application and will consider visual acuity as the primary endpoint. ISTAEs...show that Vitrase produced visual acuity in patients and a decreased hemorrhage...

New findings from University of Medicine and Dentistry of New Jersey describe advances in macular degeneration.
Biotech Week; 11/4/2009; 1003 words; ...change in mean visual acuity was seen during the follow...lines of Snellen visual acuity," wrote D.B. Roth...stabilization of visual acuity and a decreased need...Imaging is: Slack Inc., 6900 Grove Rd...Macular Degeneration, Pharmaceuticals, Photodynamics, Phototherapy...

ISTA Secures $40M Financing As It Nears Vitrase NDA Filing.
BIOWORLD Today; 11/4/2009; 911 words; Staff Writer ISTA Pharmaceuticals Inc. secured $40 million...to the FDA in visual acuity before the end of the...the NDA with visual acuity considered as the primary...compounds from AcSentient Inc., of Research Triangle...s partner, Senju Pharmaceutical Co. Ltd., of Osaka...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.